Drugmaker Aurobindo Pharma has received final approval from the US Food and Drug Administration (FDA) to manufacture and market an anaesthetic injection in the American market, the company said. The product, expected to be launched in the second quarter of 2016-17 fiscal, has an estimated market size of $5.6 million for 2015-16, it added, quoting US-based healthcare firm IMS Health.